Sanofi: Dupixent® (dupilumab) showed positive Phase 3 results in adolescents with inadequately controlled moderate-to-severe atopic dermatitis
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/6/2026
- S&P 500, Nasdaq hit record highs as Treasury yields stall, oil slips
- Oil prices fall nearly 2% as Middle East supply concerns ease
- U.S. 10-year yield climb revives dotcom-era parallels: UBS weighs in
- Goldman flags 2 key market risks if a climb in yields persists
- Shell CEO says Middle East oil flows reach 80% of prewar levels
| Regeneron (NASDAQ: REGN) | Delayed: 731.40 +4.93 (0.68%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $726.47 | 52 Week High | $592.36 | |||
| Open | $734.61 | 52 Week Low | $325.35 | |||
| Day High | $740.51 | P/E | 191.97 | |||
| Day Low | $727.16 | EPS | $3.81 | |||
| Volume | 250,298 | |||||
| SANOFI (NASDAQ: SNY) | Delayed: 39.54 +0.03 (0.08%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $39.51 | 52 Week High | $44.76 | |||
| Open | $40.05 | 52 Week Low | $36.81 | |||
| Day High | $40.05 | P/E | N/A | |||
| Day Low | $39.24 | EPS | $0.00 | |||
| Volume | 1,825,971 | |||||
